Search bioRxiv⌕ Search

Biology subjects

Adams, F.

Publications and source records attributed to Adams, F..

2 recordsLinked to original sources

Multi-scale observations of mangrove blue carbon fluxes; the NASA Carbon Monitoring System BlueFlux field campaign

The BlueFlux field campaign is supported by NASAs Carbon Monitoring System (CMS) and will develop prototype blue carbon products to inform coastal carbon management. Blue carbon is included in carbon-dioxide removal actions proposed to reduce atmospheric CO2 concentrations to mitigate climate change. Due to their high productivity and carbon storage, combined with historic losses and a wide-range of beneficial ecosystem services, the restoration and conservation of mangrove ecosystems features prominently in blue-carbon planning. The goal of BlueFlux is to carry out multi-scale measurements of CO2 and CH4 fluxes using chambers, flux towers, and aircraft and scale these to gridded products using space-based observations of forest structure and surface reflectance. The measurements cover gradients in disturbance, mainly from the history of hurricanes in the region that drive the dieback of mangroves and the formation of ghost forests. The fluxes of CH4 emissions will be contrasted with CO2 uptake to provide a more complete budget of radiative forcing and to understand the net climate benefits of blue carbon. BlueFlux demonstrates that quantifying the removals of CO2 and emissions of CH4 using a multi-scale approach can provide increased confidence in regional greenhouse-gas accounting, contribute to process-understanding, and help inform restoration and conservation efforts in the context of climate mitigation.

ecology↗

Reprogramming enriches for somatic cell clones with small scale mutations in cancer-associated genes

Recent studies demonstrated that the mutational load in human induced pluripotent stem cells (hiPSCs) is largely derived from their parental cells, but it is still unknown whether reprogramming may enrich for individual mutations. 30 hiPSC lines were analyzed by whole exome sequencing. High accuracy amplicon sequencing showed that all analyzed small scale variants pre-existed in their parental cells and that individual mutations present in small subpopulations of parental cells become enriched among hiPSC clones during reprogramming. Among those, putatively actionable driver mutations affect genes related to cell cycle control, cell death and pluripotency, and may confer a selective advantage during reprogramming. Finally, a shRNA-based experimental approach was applied to provide additional evidence for the individual impact of such genes on the reprogramming efficiency. In conclusion, we show that enriched mutations in curated onco- and tumor suppressor genes may account for an increased tumor risk and impact the clinical value of patient-derived hiPSCs.

genomics↗